|
Free Research Articles
Citations 131-140 of 789 total displayed.
|
Past content
(since May 2004):
|
Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma
- John F. DiPersio, Edward A. Stadtmauer, Auayporn Nademanee, Ivana N. M. Micallef, Patrick J. Stiff, Jonathan L. Kaufman, Richard T. Maziarz, Chitra Hosing, Stefan Früehauf, Mitchell Horwitz, Dennis Cooper, Gary Bridger, Gary Calandra, and for the 3102 Investigators
Blood 2009; 113: 5720-5726.
[Abstract]
[Full text]
[PDF]
Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors
- Ken-Hong Lim, Ayalew Tefferi, Terra L. Lasho, Christy Finke, Mrinal Patnaik, Joseph H. Butterfield, Rebecca F. McClure, Chin-Yang Li, and Animesh Pardanani
Blood 2009; 113: 5727-5736.
[Abstract]
[Full text]
[PDF]
Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid–based proteasome inhibitors
- Encouse B. Golden, Philip Y. Lam, Adel Kardosh, Kevin J. Gaffney, Enrique Cadenas, Stan G. Louie, Nicos A. Petasis, Thomas C. Chen, and Axel H. Schönthal
Blood 2009; 113: 5927-5937.
[Abstract]
[Full text]
[PDF]
Comparable survival between HIV+ and HIV– non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation
- José L. Díez-Martín, Pascual Balsalobre, Alessandro Re, Mariagrazia Michieli, José M. Ribera, Carmen Canals, Eulogio Conde, Anne Rosselet, Ian Gabriel, Rosario Varela, Bernardino Allione, Kate Cwynarski, Philippe Genet, Ildefonso Espigado, Pierre Biron, Norbert Schmitz, Anne E. Hunter, Augustin Ferrant, Gaelle Guillerm, Mark Hentrich, Manuel Jurado, Pascual Fernández, David Serrano, Giuseppe Rossi, and Anna Sureda, on behalf of the European Group for Blood and Marrow Transplantation Lymphoma Working Party
Blood 2009; 113: 6011-6014.
[Abstract]
[Full text]
[PDF]
How I treat symptomatic splenomegaly in patients with myelofibrosis
- Ruben A. Mesa
Blood 2009; 113: 5394-5400.
[Abstract]
[Full text]
[PDF]
Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study
- Lucien Noens, Marie-Anne van Lierde, Robrecht De Bock, Gregor Verhoef, Pierre Zachée, Zwi Berneman, Philippe Martiat, Philippe Mineur, Koen Van Eygen, Karen MacDonald, Sabina De Geest, Tara Albrecht, and Ivo Abraham
Blood 2009; 113: 5401-5411.
[Abstract]
[Full text]
[PDF]
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
- Ola Landgren, Robert A. Kyle, Ruth M. Pfeiffer, Jerry A. Katzmann, Neil E. Caporaso, Richard B. Hayes, Angela Dispenzieri, Shaji Kumar, Raynell J. Clark, Dalsu Baris, Robert Hoover, and S. Vincent Rajkumar
Blood 2009; 113: 5412-5417.
[Abstract]
[Full text]
[PDF]
A monoclonal gammopathy precedes multiple myeloma in most patients
- Brendan M. Weiss, Jude Abadie, Pramvir Verma, Robin S. Howard, and W. Michael Kuehl
Blood 2009; 113: 5418-5422.
[Abstract]
[Full text]
[PDF]
JAK2V617F mutation for the early diagnosis of Ph– myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis
- Francesco Dentali, Alessandro Squizzato, Lorenza Brivio, Lorena Appio, Leonardo Campiotti, Mark Crowther, Anna Maria Grandi, and Walter Ageno
Blood 2009; 113: 5617-5623.
[Abstract]
[Full text]
[PDF]
Failure to achieve a complete hematologic response at the time of a major cytogenetic response with second-generation tyrosine kinase inhibitors is associated with a poor prognosis among patients with chronic myeloid leukemia in accelerated or blast phase
- Carmen Fava, Hagop M. Kantarjian, Elias Jabbour, Susan O'Brien, Nitin Jain, Mary Beth Rios, Guillermo Garcia-Manero, Farhad Ravandi, Srdan Verstovsek, Gautam Borthakur, Jianqin Shan, and Jorge Cortes
Blood 2009; 113: 5058-5063.
[Abstract]
[Full text]
[PDF]
|
|
